Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients.
Sourisseau M, Faure E, Béhal H, Chauvet P, Srour M, Capes A, Coiteux V, Magro L, Alfandari S, Alidjinou EK, Simon N, Vuotto F, Karam M, Faure K, Yakoub-Agha I, Beauvais D. Sourisseau M, et al. Among authors: alidjinou ek. Blood Adv. 2023 Mar 14;7(5):856-865. doi: 10.1182/bloodadvances.2022008667. Blood Adv. 2023. PMID: 36350752 Free PMC article.
Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study.
Alidjinou EK, Poissy J, Ouafi M, Caplan M, Benhalima I, Goutay J, Tinez C, Faure K, Chopin MC, Yelnik C, Lambert M, Hober D, Preau S; The Lille COVID Research Network (LICORNE); Nseir S, Engelmann I. Alidjinou EK, et al. Diagnostics (Basel). 2021 Mar 3;11(3):427. doi: 10.3390/diagnostics11030427. Diagnostics (Basel). 2021. PMID: 33802451 Free PMC article.
Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19-directed CAR T-cell therapy in diffuse large B cell lymphoma.
Gazeau N, Mitra S, Nudel M, Tilmont R, Chauvet P, Srour M, Moreau AS, Varlet P, Alidjinou EK, Manier S, Morschhauser F, Labalette M, Yakoub-Agha I, Beauvais D. Gazeau N, et al. Among authors: alidjinou ek. Br J Haematol. 2023 Jul;202(2):434-436. doi: 10.1111/bjh.18775. Epub 2023 Mar 31. Br J Haematol. 2023. PMID: 36999438 No abstract available.
Combating coxsackievirus B infections.
Alhazmi A, Nekoua MP, Mercier A, Vergez I, Sane F, Alidjinou EK, Hober D. Alhazmi A, et al. Among authors: alidjinou ek. Rev Med Virol. 2023 Jan;33(1):e2406. doi: 10.1002/rmv.2406. Epub 2022 Nov 12. Rev Med Virol. 2023. PMID: 36371612 Review.
Enterovirus Antibodies: Friends and Foes.
Mbani CJ, Morvan C, Nekoua MP, Debuysschere C, Alidjinou EK, Moukassa D, Hober D. Mbani CJ, et al. Among authors: alidjinou ek. Rev Med Virol. 2024 Nov;34(6):e70004. doi: 10.1002/rmv.70004. Rev Med Virol. 2024. PMID: 39505825 Review.
Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study.
Zafilaza K, Bellet J, Truffot A, Foulongne V, Onambele MM, Salmona M, Vellas C, Périllaud-Dubois C, Mirand A, André-Garnier E, Alidjinou EK, Brichler S, Fenaux H, Bouvier-Alias M, Hartard C, Dorival C, Carrat F, Marcelin AG, Stefic K, Soulie C. Zafilaza K, et al. Among authors: alidjinou ek. Viruses. 2024 Sep 29;16(10):1542. doi: 10.3390/v16101542. Viruses. 2024. PMID: 39459877 Free PMC article.
111 results